The U.S. Food and Drug Administration (FDA) released an official statement on September 13, 2019 alerting patients and healthcare providers of a safety concern regarding the drug ranitidine. This drug is commonly bought and sold under the brand name, Zantac®. On April 1, 2020, the FDA requested that manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately, including Zantac®.
This action followed testing demonstrating toxic levels of a carcinogenic ingredient known as NDMA in certain formulations of Zantac® tablets, capsules, and oral solutions.
In response to these findings, thousands of people across the United States have filed lawsuits against Zantac® drug manufacturers for failing to warn and protect consumers from the drug’s cancer-causing effects.
If you or a loved one has been diagnosed with cancer or suffered wrongful death as a result of taking toxic Zantac® products, you may be eligible for compensation. Eric Koch can help you determine your eligibility and effectively represent your interests in seeking compensation for your damages.
1720 North Kinser Pike
Bloomington, Indiana 47404
* A free confidential case evaluation will be conducted by telephone by an attorney, paralegal, or legal assistant for the purpose of enabling the prospective client to learn more about the experience and credentials of the attorneys in the law firm and for the law firm to determine in advance whether any actual or potential conflicts of interest exist, determine in advance whether the matter is within the firm's scope of practice, make a preliminary evaluation of the merits of the matter, and evaluate whether the firm's current case load allows the firm to accept the case.